Other significant news from the ASCO annual meeting

Posted on June 5, 2012 by Sitemaster

We apologize for the slight delay in getting to other notable news from the annual meeting of the American Society for Clinical Oncology. (Other elements of the rest of life interfered.) However, here is the keypoint summary with links to the relevant abstracts: … READ MORE …

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: , , , | 5 Comments »

Educating the family doctor about prostate cancer management

Posted on September 6, 2011 by Sitemaster

The August 15 issue of American Family Physician — supposedly one of the most widely read medical journals in America — carried an article by Mohan and Schellhammer entitled “Treatment options for localized prostate cancer.” Unfortunately the full text of this article is not available on line for the average reader. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , | 4 Comments »

From Partin tables to a Partin nomogram — a 2010 update

Posted on October 20, 2010 by Sitemaster

A multi-center research team has used data from > 7,300 radical prostatectomy patients treated between 2000 and 2005 at two major medical centers to construct a new “2010 Partin nomogram” to improve prediction of pathologic outcomes after radical surgery. … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , | 3 Comments »

Prostate cancer news update, Thursday, September 11

Posted on September 11, 2008 by Sitemaster

Today’s prostate cancer update includes information on:

  • The lack of any specific connection between prostate cancer risk and a history of sexually transmitted infection
  • A review of current issues in the management of “high risk” prostate cancer patients
  • The effect the Medicare Modernization Action on the use of orchiectomy as compared to LHRH agonist therapy
  • The impact of prostate cancer treatment and outcomes of treatment on couples … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , , , , , | Leave a Comment »

Prostate cancer news update: Tuesday, 9 September

Posted on September 9, 2008 by Sitemaster

This morning’s news update deals with two newly published studies:

  • The relative effectiveness of two different types of artificial sphincter for the chronically incontinent post-treatment
  • The impact of ADT on metabolic and cardiovascular processes and the risk for significant adverse reactions as a consequence of hypogonadism … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , , , , , , , , | 2 Comments »

“Entertainment” education about prostate cancer screening

Posted on September 6, 2008 by Sitemaster

The ability to provide engaging and easily understood information about prostate cancer screening for low literacy popuations is a continuing challenge. Volk et al. have developed and evaluated an “entertainment-based” patient decision aid for prostate cancer screening, comparing its effectiveness among patients with low and high health literacy. … READ MORE …

Filed under: Diagnosis, Management | Tagged: , , , , , , | 5 Comments »

EBRT for prostate cancer and increased risk for colon cancer?

Posted on September 4, 2008 by Sitemaster

A recent report by Rapiti et al. from the Geneva Cancer Registry documents a significant increase in risk for colon but not rectum cancer after earlier external beam radiotherapy (EBRT) for prostate cancer. While it is well known that radiotherapy can induce second cancers, there has been some controversy over the risk for second malignancies after irradiation for prostate cancer. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , , | 6 Comments »

Blood calcium levels and prostate cancer risk

Posted on September 3, 2008 by Sitemaster

A Reuters report issued today quotes US-based researchers as saying that men with elevated levels of calcium in their blood may have a much higher risk of getting fatal prostate cancer than the average man with a diagnosis of prostate cancer. … READ MORE …

Filed under: Diagnosis, Management, Treatment | Tagged: , , , , , , , | Leave a Comment »

What’s hot today? Tuesday, September 2

Posted on September 2, 2008 by Sitemaster

Today’s reports address:

  • The potential prognostic significance of a tertiary Gleason pattern in pathologic analysis of prostate cancer stage following a radical prostatectomy
  • The relative safety of two types of external beam radiotherapy in treatment of patients with localized prostate cancer … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , , | Leave a Comment »

Prostate cancer news update: Monday, September 1

Posted on September 1, 2008 by Sitemaster

In today’s reports:

  • Zoledronic acid (Zometa) has confirmed it’s impact on skeletal strength in the “real world”
  • Time to recovered of “normal” testosterone levels after ADT has been measured in a prospective clinical trial
  • Acupuncture appear to work to relieve “hot flashes” in men on LHRH agonists … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , , | Leave a Comment »

Cell Genesys halts VITAL-2 GVAX trial

Posted on August 27, 2008 by Sitemaster

In another severe setback for the application of immunotherapy in the treatment of advanced prostate cancer, Cell Genesys has announced the early termination of the Phase III VITAL-2 clinical trial comparing GVAX + docetaxel to docetaxel + prednisone. … READ MORE …

Filed under: Drugs in development, Treatment | Tagged: , , , , | 2 Comments »

Two more new drugs enter Phase II trials for androgen-independent prostate cancer

Posted on August 27, 2008 by Sitemaster

ImClone Systems has announced the initiation of enrollment of patients with androgen-independent prostate cancer (AIPC) in a Phase II clinical trial with either IMC-A12 or IMC-1121B plus mitoxantrone and prednisone. … READ MORE …

Filed under: Drugs in development, Management, Treatment | Tagged: , , , , , | Leave a Comment »

Prostate cancer news update: Tuesday, August 26

Posted on August 26, 2008 by Sitemaster

There are several interesting news items today, as follows:

  • Ethnic variation in the performance of PSA and PSA density as markers for risk of prostate cancer
  • Potential underuse of active surveillance in eligible patients
  • Application of active surveillance in a 40-patient case series
  • The potential to eliminate the need for a urethral (Foley) catheter post-surgery
  • Circulating tumor cell levels as a predictor for response to androgen deprivation therapy … READ MORE …

Filed under: Diagnosis, Management, Treatment, Uncategorized | Tagged: , , , , , , , , , , , , , | 1 Comment »

Obesity, statins, and risk for prostate cancer

Posted on August 25, 2008 by Sitemaster

A recent epidemiologic study in King County, Washington, has found an increased risk for prostate cancer associated with statin use among obese men. … READ MORE …

Filed under: Prevention | Tagged: , , , , , | Leave a Comment »

Prostate cancer news update: Monday, August 25

Posted on August 25, 2008 by Sitemaster

Two reports just published would appear to confirm individual patient experiences in the treatment of advanced disease:

  • The impact of ADT on body composition
  • The effects of docetaxel chemotherapy in men aged ≥ 75 years … READ MORE …

Filed under: Management, Treatment | Tagged: , , , , , , , | Leave a Comment »

Next Page »
Follow

Get every new post delivered to your Inbox.

Join 832 other followers